Europeiska unionen - svenska - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil hydroklorid - kolorektala neoplasmer - antineoplastiska medel - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Europeiska unionen - svenska - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukemi, myeloid - antineoplastiska medel - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare b.v. - gemcitabinhydroklorid - koncentrat till infusionsvätska, lösning - 100 mg/ml - etanol, vattenfri hjälpämne; propylenglykol hjälpämne; gemcitabinhydroklorid 113,85 mg aktiv substans - gemcitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

intas pharmaceuticals limited - kapecitabin - filmdragerad tablett - 150 mg - kapecitabin 150 mg aktiv substans; laktos (vattenfri) hjälpämne - kapecitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pharos - pharmaceutical oriented services ltd - kapecitabin - filmdragerad tablett - 150 mg - kapecitabin 150 mg aktiv substans - kapecitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris limited - kapecitabin - filmdragerad tablett - 150 mg - kapecitabin 150 mg aktiv substans - kapecitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

intas pharmaceuticals limited - kapecitabin - filmdragerad tablett - 500 mg - laktos (vattenfri) hjälpämne; kapecitabin 500 mg aktiv substans - kapecitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pharos - pharmaceutical oriented services ltd - kapecitabin - filmdragerad tablett - 500 mg - kapecitabin 500 mg aktiv substans - kapecitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris limited - kapecitabin - filmdragerad tablett - 500 mg - kapecitabin 500 mg aktiv substans - kapecitabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

alfred e tiefenbacher (gmbh & co. kg) - febuxostat (vattenfritt) - filmdragerad tablett - 120 mg - mannitol hjälpämne; febuxostat (vattenfritt) 120 mg aktiv substans; natriumlaurilsulfat hjälpämne